InBody CoLtd Price To Sales vs. Total Debt

041830 Stock  KRW 22,000  450.00  2.00%   
Based on the measurements of profitability obtained from InBody CoLtd's financial statements, InBody CoLtd may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess InBody CoLtd's ability to earn profits and add value for shareholders.
For InBody CoLtd profitability analysis, we use financial ratios and fundamental drivers that measure the ability of InBody CoLtd to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well InBody CoLtd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between InBody CoLtd's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of InBody CoLtd over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between InBody CoLtd's value and its price as these two are different measures arrived at by different means. Investors typically determine if InBody CoLtd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InBody CoLtd's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

InBody CoLtd Total Debt vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining InBody CoLtd's current stock value. Our valuation model uses many indicators to compare InBody CoLtd value to that of its competitors to determine the firm's financial worth.
InBody CoLtd is rated fourth in price to sales category among its peers. It is the top company in total debt category among its peers making up about  908,537,312  of Total Debt per Price To Sales. Comparative valuation analysis is a catch-all model that can be used if you cannot value InBody CoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for InBody CoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

InBody Total Debt vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

InBody CoLtd

P/S

 = 

MV Per Share

Revenue Per Share

 = 
2.02 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

InBody CoLtd

Total Debt

 = 

Bonds

+

Notes

 = 
1.83 B
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

InBody Total Debt vs Competition

InBody CoLtd is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 46.43 Billion. InBody CoLtd holds roughly 1.83 Billion in total debt claiming about 4% of equities under Health Care industry.
Total debt  Workforce  Capitalization  Revenue  Valuation

InBody CoLtd Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in InBody CoLtd, profitability is also one of the essential criteria for including it into their portfolios because, without profit, InBody CoLtd will eventually generate negative long term returns. The profitability progress is the general direction of InBody CoLtd's change in net profit over the period of time. It can combine multiple indicators of InBody CoLtd, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
InBody Co., Ltd. provides body composition analysis solutions worldwide. InBody Co., Ltd. was founded in 1996 and is based in Mumbai, India. InBody is traded on Korean Securities Dealers Automated Quotations in South Korea.

InBody Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on InBody CoLtd. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of InBody CoLtd position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the InBody CoLtd's important profitability drivers and their relationship over time.

Use InBody CoLtd in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InBody CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InBody CoLtd will appreciate offsetting losses from the drop in the long position's value.

InBody CoLtd Pair Trading

InBody CoLtd Pair Trading Analysis

The ability to find closely correlated positions to InBody CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InBody CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InBody CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InBody CoLtd to buy it.
The correlation of InBody CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InBody CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InBody CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InBody CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your InBody CoLtd position

In addition to having InBody CoLtd in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in InBody Stock

To fully project InBody CoLtd's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of InBody CoLtd at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include InBody CoLtd's income statement, its balance sheet, and the statement of cash flows.
Potential InBody CoLtd investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although InBody CoLtd investors may work on each financial statement separately, they are all related. The changes in InBody CoLtd's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on InBody CoLtd's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.